MEN-2 is due to pathogenic variants in the RET gene (on chromosome 10q11.21), a cluster 2 proto-oncogene encoding for a receptor tyrosine kinase that plays an important role in the development of neural crest cells (62). Here, RET is linked to multiple endocrine neoplasia type 2.